Disis ML, Dang Y, Coveler AL, Childs JS, et al. A Phase I/II trial of HER-2/neu vaccine primed autologous T-cell infusions in patients with treatment refractory HER-2/neu overexpressing breast cancer. Clin Cancer Res 2023 Apr 24:CCR-22-3578. doi: 10.1158/1078-0432.CCR-22-3578.
PMID: 37093223